Sugentech Incorporate is a Korea-based company mainly engaged in the production and sale of in-vitro diagnostic test reagents. The Company is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The Company distributes its products within the domestic market and to overseas markets, including Indonesia.

Employees

144

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
01/26/01	₩4,570.00	+2.93%	1,15,018
30/26/30	₩4,440.00	+1.02%	87,788
29/26/29	₩4,395.00	-4.35%	1,21,887
28/26/28	₩4,595.00	+0.66%	96,979
23/26/23	₩4,565.00	+1.44%	1,34,603

End-of-day quote Korea S.E.

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. 01/10/2026			5-day change	1st Jan Change
4,570.00 ^KRW	+2.93%		+0.11%	-25.57%

14/08	Sugentech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
15/05	Sugentech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	6.99TCr 5.14Cr 4.58Cr 4.28Cr 3.9Cr 7.32Cr 495.38Cr 7.42Cr 52Cr 20Cr 252.39Cr 19Cr 19Cr 814.95Cr	P/E 2024	-5.35x	P/E 2025	-4.03x
Enterprise Value	3.97TCr 2.92Cr 2.6Cr 2.43Cr 2.21Cr 4.15Cr 281.25Cr 4.21Cr 29Cr 11Cr 143.3Cr 11Cr 11Cr 462.7Cr	EV / Sales 2024	3.27x	EV / Sales 2025	6.76x
Free-Float	76.84%	Yield 2024 *	-	Yield 2025	-

14/08	Sugentech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
15/05	Sugentech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
18/03	Sugentech Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
14/11	Sugentech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
29/25/29	Sugentech to divest 12.5 billion won worth of own shares	RE
29/25/29	Sugentech Inc. announced that it expects to receive KRW 12.506195 billion in funding from Synergy IB Investment Co., Ltd., Synergy-Premier Mezzanine Blind No. 1 New Technology Business Investment Fund, IBK Capital Corporation, Korea Investment & Securities Co., Ltd. and other investors	CI
14/25/14	Sugentech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
15/25/15	Sugentech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
11/25/11	Sugentech Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
11/25/11	Sugentech Inc. Auditor Raises 'Going Concern' Doubt	CI
14/24/14	Sugentech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
23/24/23	Sugentech Inc.(KOSDAQ:A253840) dropped from S&P Global BMI Index	CI
28/23/28	Tranche Update on Sugentech Inc.'s Equity Buyback Plan announced on March 29, 2023.	CI

1 day	+2.93%
1 week	+0.11%
Current month	+2.93%
1 month	+2.81%
3 months	+19.63%
6 months	-0.98%
Current year	-25.57%

Sugentech Inc. Share Price

Stocks

A253840

KR7253840003

Medical Equipment, Supplies & Distribution

Valuation: Sugentech Inc.

Chart: Sugentech Inc.

Latest news: Sugentech Inc.

Press Releases: Sugentech Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Sugentech Inc.

Latest insider transactions

Diagnostic & Testing Substances

Financials

Company Profile

Quotes

1 week	4,350	4,650
1 month	4,205	4,810
Current year	3,530	8,170
1 year	3,530	8,250
3 years	3,530	11,500
5 years	3,530	23,750
10 years	3,530	65,800

Manager	Title	Age	Since
Seong-Bum Yoo CTO	Chief Tech/Sci/R&D Officer	59	26/09/2017
Mi-Jin Sohn CEO	Chief Executive Officer	61	26/09/2017
Hae-Gwon Lee DFI	Director of Finance/CFO	56	31/03/2022

Director	Title	Age	Since
Mi-Jin Sohn BRD	Director/Board Member	61	26/09/2017
Seong-Bum Yoo BRD	Director/Board Member	59	26/09/2017
Jae-Hong Jeon BRD	Director/Board Member	51	31/03/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUGENTECH INC.	+2.93%	+0.11%	-32.70%	-36.26%	5.01Cr
ABBOTT LABORATORIES	-2.17%	-6.57%	-27.81%	-0.17%	17TCr
MEDTRONIC PLC	+0.17%	-3.20%	-9.24%	+10.31%	11TCr
STRYKER CORPORATION	-0.88%	-0.16%	-26.16%	-0.11%	11TCr
ESSILORLUXOTTICA	-0.69%	-3.57%	-47.61%	-12.45%	7.6TCr
CENCORA, INC.	+3.17%	-0.80%	-0.88%	+72.13%	5.73TCr
BECTON, DICKINSON AND COMPANY	-0.52%	-2.44%	-4.86%	-31.12%	4.88TCr
HOYA CORPORATION	+3.44%	+7.90%	+19.12%	+59.15%	5.02TCr
IDEXX LABORATORIES, INC.	-0.85%	-0.82%	-18.96%	+18.41%	4.11TCr
DEXCOM, INC.	-0.07%	-1.71%	+28.15%	-7.58%	3.26TCr
Average	+0.40%	-1.30%	-12.10%	+7.23%	6.93TCr
Weighted average by Cap.	-0.38%	-2.07%	-16.38%	+9.01%

	2024	2025
Net sales	1.01TCr 74.31L 66.14L 61.79L 56.34L 1.06Cr 72Cr 1.07Cr 7.47Cr 2.89Cr 36Cr 2.79Cr 2.73Cr 117.76Cr	941.69Cr 69.31L 61.68L 57.63L 52.55L 98.59L 67Cr 1Cr 6.96Cr 2.7Cr 34Cr 2.6Cr 2.55Cr 109.83Cr
Net income	-1.52TCr -1.12Cr -99.51L -92.98L -84.78L -1.59Cr -107.71Cr -1.61Cr -11Cr -4.35Cr -55Cr -4.2Cr -4.11Cr -177.2Cr	-2.33TCr -1.72Cr -1.53Cr -1.43Cr -1.3Cr -2.44Cr -165.29Cr -2.48Cr -17Cr -6.68Cr -84Cr -6.44Cr -6.3Cr -271.92Cr
Net Debt	-4.85TCr -3.57Cr -3.18Cr -2.97Cr -2.71Cr -5.08Cr -343.89Cr -5.15Cr -36Cr -14Cr -175.21Cr -13Cr -13Cr -565.73Cr	-3.02TCr -2.22Cr -1.98Cr -1.85Cr -1.69Cr -3.16Cr -214.12Cr -3.21Cr -22Cr -8.65Cr -109.09Cr -8.35Cr -8.17Cr -352.26Cr